Skip to Content

Affymax Inc AFFY Stock Quote

| Rating as of


Last close prices updated as of Jan 13, 2023, 10:26 AM EST | USD
  • Last Close 0.01
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.01  –  0.01
  • Year Range < 0.01  –  0.02
  • Market Cap 374,900.9500
  • Volume / Avg 4,698.0 /  5,648.5
  • Price / Sales 0.00
  • Price / Book 0.00
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis AFFY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics AFFY

Company Profile AFFY

Business Description

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

630 Fifth Avenue, 2nd Floor
New York, NY, 10020
Industry Biotechnology
Employees 2

FAQs for Affymax Inc Stock

No. AFFY does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

AFFY’s market cap is 374,900.95.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

AFFY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare AFFY’s historical performance against its industry peers and the overall market.